NCATS is jointly hosting the first 2019 RE(ACT) Congress America event that will bring together leading scientific experts, patients and advocates to discuss rare diseases research. The goal is to facilitate and promote international scientific cooperation in this field. The event, which takes place May 8-11 in Toronto, is the first to be held in North America.
Panel discussion topics include:
- Gene editing
- Cell and gene therapies and their clinical application
- Multi-national patient registries
- Patient-focused drug development
- Therapeutic approaches for rare diseases
- Indigenous populations
NCATS’ Office of Rare Diseases Research organized the event in collaboration with the Canadian Organization for Rare Disorders (CORD), the Canadian Institutes of Health (CIHR), Genome Canada and the Children’s Hospital of Eastern Ontario (CHEO). Registration fees vary and pre-registration is required.